Nitric oxide is a central common metabolite in vascular dysfunction associated with diseases of human pregnancy

Current Vascular Pharmacology

Volumn 14, Issue 3, 2016, Pages 237-259

  Leiva, Andrea ^a   Fuenzalida, Bárbara ^a   Barros, Eric ^a   Sobrevia, Bastián ^a   Salsoso, Rocío ^a,d   Sáez, Tamara ^a   Villalobos, Roberto ^a   Silva, Luis ^a   Chiarello, Indira ^a   Toledo, Fernando ^b   Gutiérrez, Jaime ^a,c   Sanhueza, Carlos ^a   Pardo, Fabián ^a   Sobrevia, Luis ^a,d,e  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DEL BÍO BÍO   (Chile)

^c UNIVERSIDAD SAN SEBASTIÁN   (Chile)

^d UNIVERSITY OF SEVILLE   (Spain)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Diabetes; Endothelium; Fetoplacental; Hypercholesterolaemia; Nitric oxide; Preeclampsia

Indexed keywords

CALMODULIN; CITRULLINE; NITRIC OXIDE;

ARTICLE; ENZYME ACTIVITY; FETUS CIRCULATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; METABOLITE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; VASCULAR DISEASE; WESTERN BLOTTING; ANIMAL; FEMALE; METABOLISM; PHYSIOLOGY; PLACENTA; PREGNANCY COMPLICATION; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; NITRIC OXIDE; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; VASCULAR DISEASES;

EID: 84964017449     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161114666160222115158     Document Type: Article

References (331)

1. Mudd LM, Pivarnik J, Holzman CB, Paneth N, Pfeiffer K, Chung H. Leisure-time physical activity in pregnancy and the birth weight distribution: where is the effect? J Phys Act Health 2012; 9(8): 1168-77
2. Leiva A, de Medina CD, Salsoso R, et al. Maternal hypercholesterolaemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II. Arterioscler Thromb Vasc Biol 2013; 33(10): 2444-53
3. Leiva A, Salsoso R, Sáez T, Sanhueza C, Pardo F, Sobrevia L. Cross-sectional and longitudinal lipid determination studies in pregnant women reveal an association between increased maternal LDL cholesterol concentrations and reduced human umbilical vein relaxation. Placenta 2015; 36(8): 895-902
4. Leiva A, Fuenzalida B, Westermeier F, et al. Role for tetrahydrobiopterin in the fetoplacental endothelial dysfunction in maternal supraphysiological hypercholesterolaemia. Oxid Med Cell Longev 2015; 2015: 5346327
5. Westermeier F, Sáez PJ, Villalobos-Labra R, Sobrevia L, Farías-Jofré M. Programming of fetal insulin resistance in pregnancies with maternal obesity by er stress and inflammation. Biomed Res Int 2014; 2014: 917672
6. Alexander BT, Dasinger JH, Intapad S. Fetal programming and cardiovascular pathology. Compr Physiol 2015; 5(2): 997-1025
7. Tan HC, Roberts J, Catov J, Krishnamurthy R, Shypailo R, Bacha F. Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood. Pediatric Diabetes 2015; 16(6): 419-26
8. Ingvorsen C, Brix S, Ozanne SE, Hellgren LI. The effect of maternal Inflammation on foetal programming of metabolic disease. Acta Physiologica 2015; 214(4): 440-49
9. Pardo F, Arroyo P, Salomón C, et al. Role of equilibrative adenosine transporters and adenosine receptors as modulators of the human placental endothelium in gestational diabetes mellitus. Placenta 2013; 34(12): 1121-7
10. Pardo F, Silva L, Salsoso R, et al. Fetoplacental endothelial dysfunction in maternal hypercholesterolaemia and obesity in pregnancy. Physiol Mini Revs 2014; 7(5): 60-76
11. Pardo F, Silva L, Sáez T, et al. Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond) 2015; 39(8): 1264-73
12. Leiva A, Pardo F, Ramírez MA, Farías M, Casanello P, Sobrevia L. Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy. Exp Diabetes Res 2011; 2011: 349286
13. Leiva A, de Medina CD, Guzmán-Gutierrez E, Pardo F, Sobrevia L. Maternal hypercholesterolaemia in gestational diabetes and the association with placental endothelial dysfunction. In: Sobrevia L, Ed. Gestational diabetes – causes, diagnosis and treatment. InTech: Rijeka, Shangai 2013; pp. 103-34
14. Sobrevia L, Myatt L, Rice G. Diseases of pregnancy and fetal programming: cell and molecular mechanisms. Biomed Res Int 2014; 2014: 937050
15. Fox SB, Khong TY. Lack of innervation of human umbilical cord. an immunohistological and histochemical study. Placenta 1990; 11(1): 59-62
16. Marzioni D, Tamagnone L, Capparuccia L, et al. Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. Dev Dyn 2004; 231(4): 839-48
17. Sobrevia L, Abarzúa F, Nien JK, et al. Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta 2011; 32(Suppl 2): 159-64
18. Sobrevia L, Salsoso R, Sáez T, Sanhueza C, Pardo F, Leiva A. Insulin therapy and fetoplacental vascular function in gestational diabetes mellitus. Exp Physiol 2015; 100(3): 231-8
19. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the european society of hypertension. J Hypertens 2005; 23(1): 7-17
20. Escudero C, Casanello P, Sobrevia L. Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta 2008; 29(9): 816-25
21. Escudero C, Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008; 29(6): 469-83
22. Mate A, Vázquez CM, Leiva A, Sobrevia L. New therapeutic approaches to treating hypertension in pregnancy. Drug Discov Today 2012; 17(23-24): 1307-15
23. Salsoso R, Guzmán-Gutiérrez E, Sáez T, et al. Insulin restores Larginine transport requiring adenosine receptors activation in umbilical vein endothelium from late-onset preeclampsia. Placenta 2015; 36(3): 287-96
24. Westermeier F, Salomón C, González M, et al. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes 2011; 60(6): 1677-87
25. Westermeier F, Salomón C, Farías M, et al. Insulin requires normal expression and signaling of insulin receptor a to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium. FASEB J 2015; 29(1): 37-49
26. Salomon C, Westermeier F, Puebla C, et al. Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS One 2012; 7(7): e40578
27. Guzmán-Gutiérrez E, Arroyo P, Salsoso R, et al. Role of insulin and adenosine in the human placenta microvascular and macrovascular endothelial cell dysfunction in gestational diabetes mellitus. Microcirculation 2014; 21(1): 26-37
28. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327(6122): 523-6
29. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflügers Arch 2010; 459(6): 807-16
30. Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006; 176(Pt 1): 213-54
31. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012; 33(7): 829-37
32. Crabtree MJ, Channon KM. Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease. Nitric Oxide 2011; 25(2): 81-8
33. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122(4): 369-82
34. Fornero S, Bassino E, Ramella R, et al. Obligatory role for endothelial heparan sulphate proteoglycans and caveolae internalization in catestatin-dependent eNOS activation. Biomed Res Int 2014; 2014: 783623
35. García-Cardeña G, Gimbrone MA Jr. Biomechanical modulation of endothelial phenotype: implications for health and disease. In: Moncada S, Higgs A, Eds. The vascular endothelium II. Springer: Berlin, Heidelberg 2006; pp. 79-95
36. Rath G, Dessy C, Feron O. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation. J Physiol Pharmacol 2009; 60(Suppl 4): 105-9
37. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 2003; 284(1): R1-12
38. Thomas D, Liu X, Kantrow S, Lancaster J. The biological lifetime of nitric oxide: Implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci USA 2001; 98(1): 355-60
39. Yoshida K, Kasama K, Kitabatake M, Imai M. Biotransformation of nitric oxide, nitrite and nitrate. Int Arch Occup Environ Health 1983; 52(2): 103-15
40. Rafikov R, Fonseca FV, Kumar S, et al. eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol 2011; 210(3): 271-84
41. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000; 347(1): 1-16
42. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 1999; 399(6736): 601-05
43. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 2001; 88(11): E68-75
44. Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 2010; 459(6): 793-806
45. Li H, Förstermann U. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 2009; 15(27): 3133-45
46. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 111(13): 1708-14
47. González M, Gallardo V, Rodríguez N, et al. Insulin-stimulated Larginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. J Cell Physiol 2011; 226(11): 2916-24
48. González M, Rojas S, Avila P, et al. Insulin reverses d-glucose– increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells. PLoS One 2015; 10(4): e0122398
49. Ridnour LA, Thomas DD, Mancardi D, et al. The Chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 2004; 385(1): 1-10
50. Staff AC, Benton SJ, von Dadelszen P, et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension 2013; 61(5): 932-42
51. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol 2013; 122: 1122e31
52. Sobrevia L, Guzmán-Gutiérrez E, Westermeier F, et al. Fetoplacental vascular pathophysiology in preeclampsia. In: Pandalai SG, Ed. Recent Research Development in Physiology. Research Signpost, India 2012; pp. 105-58
53. Chen YP, Lu YP, Li J, et al. Fetal and maternal angiotensin (1-7) are associated with preterm birth. J Hypertens 2014; 32(9): 1833-41
54. Lin S, Leonard D, Co MA, et al. Pre-eclampsia has an adverse impact on maternal and fetal health. Transl Res 2015; 165(4): 449-63
55. Tranquilli AL. Introduction to ISSHP new classification of preeclampsia. Pregnancy Hypertens 2013; 3(2): 58-59
56. Myatt L, Redman CW, Staff AC, et al. Strategy for standardization of preeclampsia research study design. Hypertension 2014; 63(6): 1293-1301
57. Myatt L, Roberts JM. Preeclampsia: syndrome or disease? Curr Hyperten Rep 2015; 17(11): 83
58. Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf) 2013; 208(3): 224-33
59. Boeldt DS, Hankes AC, Alvarez RE, et al. Pregnancy programming and preeclampsia: identifying a human endothelial model to study pregnancy-adapted endothelial function and endothelial adaptive failure in preeclamptic subjects. Adv Exp Med Biol 2014; 814: 27-47
60. Quinn MJ. Pre-eclampsia -The “uterine reinnervation” view. Med Hypotheses 2014; 83(5): 575-9
61. D'Anna R, Baviera G, Corrado F, et al. Neurokinin b and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. Brit J Obstet Gynecol 2004; 111(10): 1046-50
62. Teran E, Escudero C, Vivero S, Molina G, Calle A. NO in early pregnancy and development of preeclampsia. Hypertension 2006; 47(4): e17
63. Benedetti G, Morais KL, Guerreiro JR, et al. Bothrops jararaca peptide with anti hypertensive action normalizes endothelium dysfunction involved in physiopathology of preeclampsia. PLoS One 2011; 6(8): e23680
64. González-Garrido Chem JA, Olivares-Corichi IM, Tovar-Rodriguez JM, et al. Influence of the AT(2) receptor on the Larginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia. J Hum Hypertens 2013; 27(6): 355-61
65. López-Jaramillo P, Arenas WD, García RG, Rincon MY, López M. The role of the L-arginine-nitric oxide pathway in preeclampsia. Ther Adv Cardiovasc Dis 2008; 2(4): 261-75
66. Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol 2014; 10(5): 372
67. Noris M, Todeschini M, Cassis P, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004; 43(3): 614-22
68. Hata T, Hashimoto M, Kanenishi K, Akiyama M, Yanagihara T, Masumura S. Maternal circulating nitrite levels are decreased in both normal normotensive pregnancies and pregnancies with preeclampsia. Gynecol Obstet Invest 1999; 48(2): 93-7
69. Adu-Bonsaffoh K, Antwi DA, Obed SA, Gyan B. Nitric oxide dysregulation in the pathogenesis of preeclampsia among ghanaian women. Integr Blood Press Control 2015; 19(8): 1-6
70. Rugolo LM, de Sá MP, Kurokawa CS, et al. There is no difference in nitric oxide metabolites and neonatal outcome between premature infants born to pre-eclamptic and those born to normotensive women. Paediatr Int Child Health 2015; 35(1): 47-52
71. Escudero C, Bertoglia P, Hernandez M, et al. Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late-and early-onset preeclampsia. Purinergic Signal 2013; 9(2): 215-26
72. Braekke K, Ueland PM, Harsem NK, Staff AC. Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. Pediatr Res 2009; 66(4): 411-15
73. Tamás P, Bódis J, Sulyok E, et al. L-arginine metabolism in earlyonset and late-onset pre eclamptic pregnancies. Scand J Clin Lab Invest 2013; 73(5): 436-43
74. Alpoim PN, Gomes KB, Pinheiro Mde B, et al. Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia. Nitric Oxide 2014; 42: 19-23
75. Li H, Li L, Tang X, Yang F, Yang KX. Placental mesenchymal dysplasia: a case of a normal-appearing fetus with intrauterine growth restriction. Int J Clin Exp Pathol 2014; 7(8): 5302-7
76. Smith-Jackson K, Hentschke MR, Poli-de-Figueiredo CE, et al. Placental expression of eNOS, iNOS and the major protein components of caveolae in women with pre-eclampsia. Placenta 2015; 36(5): 607-10
77. Wang X, Athayde N, Trudinger B. Maternal plasma from women with umbilical placental vascular disease does not affect endothelial cell mRNA expression of nitric oxide synthase. J Soc Gynecol Investig 2004; 11(3): 149-53
78. Krupp J, Boeldt DS, Yi FX, et al. The loss of sustained Ca(2+) signaling underlies suppressed endothelial nitric oxide production in preeclamptic pregnancies: implications for new therapy. Am J Physiol 2013; 305(7): H969-79
79. Vignini A, Cecati M, Nanetti L, et al. Placental expression of endothelial and inducible nitric oxide synthase and NO metabolism in gestational hypertension: a case-control study. J Matern Fetal Neonatal Med 2015; 26(4): 1-6
80. Cindrova-Davies T, Sanders DA, Burton GJ, Charnock-Jones DS. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res 2011; 89(3): 671-79
81. Prieto CP, Krause BJ, Quezada C, San Martin R, Sobrevia L, Casanello P. Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium. Placenta 2011; 32(12): 932-40
82. Kukor Z, Mészáros G, Hertelendy F, Tóth M. Calcium-dependent nitric oxide synthesis is potently stimulated by tetrahydrobiopterin in human primordial placenta. Placenta 1996; 17(1): 69-73
83. Tóth M. Role of tetrahydrobiopterin in the regulation of activity of human placental nitric oxide synthase in normal and pre-eclamptic pregnancies. Orv Hetil 2002; 143(8): 391-8
84. Kukor Z, Valent S. Nitric oxide and preeclampsia. Orv Hetil 2010; 151(52): 2125-35
85. Mitchell BM, Cook LG, Danchuk S, Puschett JB. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension. Am J Hypertens 2007; 20(12): 1297-1304
86. Bambrana V, Dayanand CD, Kotur PP. Is xanthine oxidase a marker in pre-eclampsia? A case-control study. J Clin Diagn Res 2015; 9(10): BC01-3
87. Bolnick JM, Kilburn BA, Bolnick AD, et al. Sildenafil stimulates human trophoblast invasion through nitric oxide and guanosine 3', 5'-cyclic monophosphate signaling. Fertil Steril 2015; 103(6): 1587-95.e1-2
88. Jiang F, Li J, Wu G, et al. Upregulation of microRNA-335 and microRNA-584 contributes to the pathogenesis of severe preeclampsia through downregulation of endothelial nitric oxide synthase. Mol Med Rep 2015; 12(4): 5383-90
89. Matsubara K, Higaki T, Matsubara Y, Nawa A. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci 2015; 16(3): 4600-14
90. Bird IM. Endothelial nitric oxide synthase activation and nitric oxide function: new light through old windows. J Endocrinol 2011; 210(3): 239-41
91. Uusi-Rasi K, Karkkainen MU, Lamberg-Allardt CJ. Calcium intake in health maintenance -a systematic review. Food Nutr Res 2013; 57: 21082
92. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, P.C. Group. Antiplatelet agents for prevention of pre-eclampsia: a metaanalysis of individual patient data. Lancet 2007; 369(9575): 1791-98
93. Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. Brit J Obstet Gynecol 2007; 114(8): 933-43
94. Sobrevia L, Sáez T, Fuenzalida B, et al. Transplacental transport of calcium in health and disease. In: Belizán J, Uauy R, Carmuega E. Eds. Calcium and Vitamin D Role in Bone Health and Beyond. Lenguamadre/Pentapir: Buenos Aires, Argentina 2012; pp. 139-64
95. Jiang R, Cai J, Zhu Z, et al. Hypoxic trophoblast HMGB1 induces endothelial cell hyperpermeability via the TRL-4/caveolin-1 pathway. J Immunol 2014; 193(10): 5000-12
96. Choi S, Kim JA, Na HY, et al. NADPH oxidase 2-derived superoxide downregulates endothelial KCa3.1 in preeclampsia. Free Radic Biol Med 2013; 57: 10-21
97. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 1998; 16(1): 93-104
98. Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006; 45(3): 189-200
99. Doridot L, Châtre L, Ducat A, et al. Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a preeclampsia-associated gene. Antioxid Redox Signal 2014; 21(6): 819-34
100. Dechend R, Viedt C, Müller DN, et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003; 107(12): 1632-9
101. Cui XL, Brockman D, Campos B, Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 2006; 27(4-5): 422-31
102. Guedes-Martins L, Silva E, Gaio AR. Fetal-maternal interface impedance parallels local NADPH oxidase related superoxide production. Redox Biology 2015; 5: 114-23
103. Yildirim A, Altinkaynak K, Aksoy H, Sahin YN, Akcay F. Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia. Cell Biochem Funct 2004; 22(4): 213-7
104. Karabulut AB, Kafkasli A, Burak F, Gozukara EM. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 2005; 23(4): 279-83
105. Bernardi FC, Vuolo F, Petronilho F, Michels M, Ritter C, Dal-Pizzol F. Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in the plasma and placentae from preeclamptic patients. An Acad Bras Cienc 2015; 87(2): 713-9
106. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000; 156(1): 321-31
107. Webster RP, Roberts VH, Myatt L. Protein nitration in placenta -functional significance. Placenta 2008; 29(12): 985-94
108. Chang EY, Menard MK, Vermillion ST, Husley T, Ebeling M. The association between hyaline membrane disease and preeclampsia. Am J Obstet Gynecol 2004; 191(4): 1414-17
109. Jelin AC, Cheng YW, Shaffer BL, Kaimal AJ, Little SE, Caughey AB. Early-onset preeclampsia and neonatal outcomes. J Matern Fetal Neonatal Med 2010; 23(5): 389-392
110. Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156(4): 532-6
111. Kafkaslı A, Türkçüoğlu I, Turhan U. Maternal, fetal and perinatal characteristics of preeclampsia cases with and without abnormalities in uterine artery doppler indexes. J Matern Fetal Neonatal Med 2013; 26(9): 936-40
112. Verlohren S, Melchiore K, Khalil A, Thilaganathan B. Uterine artery doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset preeclampsia. Ultrasound Obstet Gynecol 2014; 44(3): 293-8
113. Madazli R, Yuksel MA, Imamoglu M, et al. Comparison of clinical and perinatal outcomes in early-and late-onset preeclampsia. Arch Gynecol Obstet 2014; 290(1): 53-7
114. Kornacki J, Skrzypczak J. Results of doppler examinations in fetuses of mothers with early-and late-onset preeclampsia. Ginekol Pol 2014; 85(7): 504-8
115. Tayal D, Goswami B, Patra SK, Tripathi R, Khaneja A. Association of inflammatory cytokines, lipid peroxidation end products and nitric oxide with the clinical severity and fetal outcome in preeclampsia in Indian women. Indian J Clin Biochem 2014; 29(2): 139-44
116. Oyston CJ, Stanley JL, Baker PN. Potential targets for the treatment of preeclampsia. Expert Opin Ther Targets 2015; 19(11): 1517-30
117. Leffert LR. What's new in obstetric anesthesia? Focus PE. Int J Obstet Anesthesia 2015; 24(3): 264-71
118. Cotechini T, Graham CH. Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? Placenta 2015; 36(8): 960-6
119. Guerci P, Vial F, Feugeas J, et al. Cerebral oximetry assessed by near-infrared spectrometry during PE: an observational study: impact of magnesium sulfate administration. Critical Care Med 2014; 42(11): 2379-86
120. Chen Q, Zhao M, Guo F, et al. The reduction of circulating levels of IL-6 in pregnant women with preeclampsia by magnesium sulphate and nifedipine: In vitro evidence for potential mechanisms. Placenta 2015; 36(6): 661-6
121. Gortzak-Uzan L, Mezad D, Smolin A, et al. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial. J Reprod Med 2005; 50(11): 817-20
122. Lu J, Pfister M, Ferrari P, et al. Pharmacokineticpharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clinical Pharmacokinetics 2002; 41(13): 1105-13
123. Sherwin CM, Balch A, Campbell SC, et al. Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. Basic & Clinical Pharmacology & Toxicology. 2014; 114(4): 318-22
124. Nakazawa H, Uchida A, Minamitani T, et al. Factors affecting maternal serum magnesium levels during long-term magnesium sulfate tocolysis in singleton and twin pregnancy. J Obstet Gynaecol Res 2015; 41(8): 1178-84
125. Maia SB, Katz L, Neto CN, et al. Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe pre-eclampsia. Int J Gynaecol Obstet 2014; 126(3): 260-4
126. Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. The Cochrane Database of Systematic Reviews 2009; 21(1): CD004661
127. DeSousa J, Tong M, Wei J, Chamley L, Stone P, Chen Q. The antiinflammatory effect of calcium for preventing endothelial cell activation in preeclampsia. J Hum Hypertens 2015; July 9: doi:10.1038/jhh.201.73
128. American Diabetes Association. Standards of medical care in diabetes--2015. Diabetes Care 2015; 38(1): S8-77
129. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 2007; 30(Suppl 2): 251-60
130. Reece EA, Leguizamón G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009; 373(9677): 1789-97
131. Belmar C, Salinas P, Becker J, et al. Incidencia de diabetes gestacional según distintos métodos diagnostico y sus implicancias clínicas. Rev Chil Obstet Ginecol 2004; 69(1): 2-7
132. Huidobro A, Fulford A, Carrasco E. Incidence of gestational diabetes and relationship to obesity in Chilean pregnant women. Rev Med Chil 2004; 132(8): 931-8
133. American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care 2014; 37(1): S14-80
134. Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence-effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 2015; 213(3): 310-7
135. Mpondo BC, Ernest A, Dee HE. Gestational diabetes mellitus: challenges in diagnosis and management. J Diabetes Metab Disord 2015; 14(1): 42
136. Olmos PR, Borzone GR, Olmos RI. Gestational diabetes and prepregnancy overweight: possible factors involved in newborn macrosomia. J Obstet Gynaecol Res 2012; 38(1): 208-14
137. Olmos PR, Araya-Del-Pino AP, González-Carvello CA, et al. Near-optimal glycemic control in Chilean women with pregestational type-2 diabetes: persistent macrosomia relates to maternal pre-pregnancy overweight. Diabetes Res Clin Pract 2009; 85(1): 53-60
138. Verier-Mine O. Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes Metab 2010; 36(6): 595-616
139. Ministerio de Salud de Chile, MINSAL. Encuesta Nacional de Salud ENS Chile 2009-2010; 2011: 1-1064
140. Hickman MA, McBride R, Boggess KA, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol 2013; 30(6): 483-90
141. Hiden U, Lang I, Ghaffari-Tabrizi N, Gauster M, Lang U, Desoye G. Insulin action on the human placental endothelium in normal and diabetic pregnancy. Curr Vasc Pharmacol 2009; 7(4): 460-6
142. Ijäs H, Morin-Papunen L, Keränen AK, et al. Pre-pregnancy overweight overtakes gestational diabetes as a risk factor for subsequent metabolic syndrome. Eur J Endocrinol 2013; 169(5): 605-11
143. Bentley-Lewis R, Huynh J, Xiong G, et al. Metabolomic profiling in the prediction of gestational diabetes mellitus. Diabetologia 2015; 58(6): 1329-32
144. Lehmann R, Friedrich T, Krebiehl G, et al. Metabolic profiles during an oral glucose tolerance test in pregnant women with and without gestational diabetes. Exp Clin Endocrinol Diabetes 2015; 123(7): 483-38
145. Enquobahrie DA, Denis M, Tadesse MG, et al. Maternal early pregnancy serum metabolites and risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2015; 100(11): 4348-56
146. Pinto J, Almeida LM, Martins AS, et al. Prediction of gestational diabetes through NMR metabolomics of maternal blood. J Proteome Res 2015; 14(6): 2696-706
147. Blue EK, Sheehan BM, Nuss ZV, et al. Epigenetic regulation of placenta-specific 8 contributes to altered function of endothelial colony-forming cells exposed to intrauterine gestational diabetes mellitus. Diabetes 2015; 64(7): 2664-75
148. Di Fulvio P, Pandolfi A, Formoso G, et al. Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes. Nutr Metab Cardiovasc Dis 2014; 24(12): 1337-45
149. Leach L. Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation 2011; 18(4); 263-9
150. Mordwinkin NM, Ouzounian JG, Yedigarova L, Montoro MN, Louie SG, Rodgers KE. Alteration of endothelial function markers in women with gestational diabetes and their fetuses. J Matern Fetal Neonatal Med 2013; 26(5): 507-12
151. Mittermayer F, Mayer BX, Meyer A, et al. Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes. Diabetologia 2002; 45(10): 1372-8
152. Vásquez G, Sanhueza F, Vásquez R, et al. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 2004; 560(Pt 1): 111-22
153. Sobrevia L, Yudilevich DL, Mann GE. Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J Physiol 1997; 499(Pt 1): 135-40
154. Farías M, Puebla C, Westermeier F, et al. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBP alpha in human umbilical vein endothelial cells from gestational diabetes. Cardiovasc Res 2010;86 (1): 45-54
155. Thomas SR, Chen K, Keaney JF. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal 2003; 5(2): 181-94
156. Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006; 72(11): 1493-505
157. Araújo JR, Keating E, Martel F. Impact of gestational diabetes mellitus in the maternal-to fetal transport of nutrients. Curr Diab Rep 2015; 15(2): 569
158. Lappas M, Hiden U, Desoye G, Froehlich J, Haugel-de-Mouzon S, Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antiox Redox Signal 2011; 15(12): 3061-100
159. Yang C, Guo ZR, Hu XS, et al. A prospective study on the association between control of blood pressure and incidence of type 2 diabetes mellitus. Zhonghua Liu Xing Bing Xue Za Zhi 2010; 31(3): 260-63
160. Vásquez R, Farías M, Vega JL, et al. Activation of mitogenactivated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol 2007; 212(3): 626-32
161. Schönfelder G, John M, Hopp H, Fuhr N, van Der Giet M, Paul M. Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 1996; 10(7): 777-84
162. Guzmán-Gutiérrez E, Westermeier F, Salomón C, et al. Insulinincreased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium. PLoS One 2012; 7(7): e41705
163. Vásquez-Vivar J, Kalyanaraman B, Martásek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95(16): 9220-5
164. Karbach S, Wenzel P, Waisman A, Munzel T, Daiber A. eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation. Curr Pharm Des 2014; 20(22): 3579-94
165. Mangge H, Becker K, Fuchs D, Gostner JM. Antioxidants, inflammation and cardiovascular disease. World J Cardiol 2014; 6(6): 462-77
166. Heitzer T, Krohn K, Albers S, Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 2000; 43(11): 1435-8
167. Cai S, Khoo J, Mussa S, Alp NJ, Channon KM. Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerization. Diabetologia 2005; 48(9): 1933-40
168. Vladic N, Ge ZD, Leucker T, et al. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol 2011; 301(5): H2130-9
169. Cai H, Liu D, Garcia JG. CaM kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc Res 2008; 77(1): 30-4
170. Kobayashi T, Nemoto S, Ishida K, Taguchi K, Matsumoto T, Kamata K. Involvement of CaM kinase II in the impairment of endothelial function and eNOS activity in aortas of type 2 diabetic rats. Clin Sci 2012; 123(6): 375-86
171. Wyatt AW, Steinert JR, Wheeler-Jones CP, et al. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calciuminsensitive mechanism. FASEB J 2002; 16(12): 1584-94
172. Sobrevia L. Diabetes induces modulation of L-arginine and adenosine transport and metabolism and human endothelial cells: implications for nitric oxide synthase. PhD dissertation. Strand (London): University of London 1996
173. Anaya HA, Yi FX, Boeldt DS, et al. Changes in Ca2+ Signaling and nitric oxide output by human umbilical vein endothelium in diabetic and gestational diabetic pregnancies. Biol Reprod 2015; 93(3): 60
174. Sobrevia L, Cesare P, Yudilevich DL, Mann GE. Diabetes-induced activation of system y + and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol 1995; 15: 183-92
175. Figueroa R, Martinez E, Fayngersh RP, Tejani N, Mohazzab-H KM, Wolin MS. Alterations in relaxation to lactate and H2O2 in human placental vessels from gestational diabetic pregnancies. Am J Physiol 2000; 278(3): H706-13
176. von Mandach U, Lauth D, Huch R. Maternal and fetal nitric oxide production in normal and abnormal pregnancy. J Matern Fetal Neonatal Med 2003; 13(1): 22-7
177. San Martin R, Sobrevia L. Gestational diabetes and the adenosine/ L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 2006; 27(1): 1-10
178. Biri A, Onan A, Devrim E, Babacan F, Kavutcu M, Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 2006; 27(2-3): 327-32
179. Westermeier F, Puebla C, Vega JL, et al. Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol 2009; 7(4): 435-49
180. Peuchant E, Brun JL, Rigalleau V, et al. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 2004; 37(4): 293-8
181. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010; 2010: 453-892
182. Topcuoglu S, Karatekin G, Yavuz T, et al. The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers. Diabetes Res Clin Pract 2015; 109(1): 104-9
183. Kahn S, Ferrannini E, Goldfine A, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab 2011; 96(6): 1654-63
184. Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vas Med 2012; 2012: 918627
185. Sarikabadayi YU, Aydemir O, Aydemir C, et al. Umbilical cord oxidative stress in infants of diabetic mothers and its relation to maternal hyperglycemia. J Pediatr Endocrinol Metab 2011; 24(9-10): 671-4
186. Sultan S, Liu W, Peng Y, Roberts W, Whitelaw D, Graham A. The role of maternal gestational diabetes in inducing fetal endothelial dysfunction. J Cell Physiol 2015; 230(11): 2695-705
187. Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005; 183(2): 259-67
188. Karbach S, Jansen T, Horke S, et al. Hyperglycemia and oxidative stress in cultured endothelial cells—a comparison of primary endothelial cells with an immortalized endothelial cell line. J Diabetes Complications 2012; 26(3): 155-62
189. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87(4): 1620-24
190. Pacher P, Beckman J, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87(1): 315-424
191. Horváth EM, Magenheim R, Kugler E, et al. Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia 2009; 52(9): 1935-43
192. Johnston PC, Powell LA, McCance DR, et al. Placental protein tyrosine nitration and MAPK in type 1 diabetic pre-eclampsia: impact of antioxidant vitamin supplementation. J Diabetes Complications 2013; 27(4): 322-7
193. Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998; 21(Suppl 2): B79-84
194. Seabra G, Saunders C, de Carvalho Padilha P, et al. Association between maternal glucose levels during pregnancy and gestational diabetes mellitus: an analytical cross-sectional study. Diabetol Metab Syndr 2015; 7(17): 1-7
195. Schmidt MI, Duncan BB, Reichelt AJ, et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001; 24(7): 1151-5
196. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60(3): 349-56
197. Veille JC, Hanson R, Sivakoff M, Hoen H, Ben-Ami M. Fetal cardiac size in normal, intrauterine growth retarded, and diabetic pregnancies. Am J Perinatol 1993; 10(4): 275-9
198. Chu C, Gui YH, Ren YY, Shi LY. The impacts of maternal gestational diabetes mellitus (GDM) on fetal hearts. Biomed Environ Sci 2012; 25(1): 15-22
199. Pietryga M, Brazert J, Wender-Ozegowska E, Dubiel M, Gudmundsson S. Placental doppler velocimetry in gestational diabetes mellitus. J Perinat Med 2006; 34(2): 108-10
200. Quintero-Prado R, Bugatto F, Sánchez-Martín P, Fajardo-Expósito MA, Torrejón R, Bartha JL. The influence of placental perfusion on birthweight in women with gestational diabetes. J Matern Fetal Neonatal Med 2016; 29(1): 32-5
201. Tan AE, Norizah WM, Rahman HA, Aziz BA, Cheah FC. Umbilical artery resistance index in diabetic pregnancies: the associations with fetal outcome and neonatal septal hypertrophic cardiomyopathy. J Obstet Gynaecol Res 2005; 31(4): 296-301
202. Leung WC, Lam H, Lee CP, Lao TT. doppler study of the umbilical and fetal middle cerebral arteries in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2004; 24(5): 534-37
203. To WW, Mok CK. Fetal umbilical arterial and venous doppler measurements in gestational diabetic and nondiabetic pregnancies near term. J Matern Fetal Neonatal Med 2009; 22(12): 1176-82
204. Thiebaugeorges O, Guyard-Boileau B. Obstetrical care in gestational diabetes and management of preterm labor. Diabetes Metab 2010; 36(6): 672-81
205. Shabani Zanjani M, Nasirzadeh R, Fereshtehnejad SM, Yoonesi A, Alemzadeh SA, Askari S. Fetal cerebral hemodynamic in gestational diabetic versus normal pregnancies: a doppler velocimetry of middle cerebral and umbilical arteries. Acta Neurol Belg 2014; 114(1): 15-23
206. Atay AE, Simsek H, Demir B, et al. Noninvasive assessment of subclinical atherosclerosis in normotensive gravidae with gestational diabetes. Herz 2014a; 39(5): 627-32
207. Pontes IE, Afra KF, Silva JR, Borges PS, Clough GF, Alves JG. Microvascular reactivity in women with gestational diabetes mellitus studied during pregnancy. Diabetol Metab Syndr 2015; 7(27): 1-6
208. Li JW, He SY, Liu P, Luo L, Zhao L, Xiao YB. Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc Disord 2014; 29(14): 132
209. Atay AE, Akbas H, Tumer C, et al. The association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes. Clin Nephrol 2014b; 81(2): 105-11
210. Roca-Rodríguez MM, López-Tinoco C, Murri M, et al. Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus. J Endocrinol Invest 2014; 37(6): 503-9
211. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Tratment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106(25): 3143-421
212. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011. Update: a report from the American Heart Association. Circulation 2011; 123(4): e18-e209
213. Baardman ME, du Marchie Sarvaas GJ, de Walle HE, et al. Impact of introduction of 20-week ultrasound scan on prevalence and fetal and neonatal outcomes in cases of selected severe congenital heart defects in the Netherlands. Ultrasound Obstet Gynecol 2014; 44(1): 58-63
214. Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod Sci 2009; 16(5): 431-37
215. Barrett H, Dekker M, McIntyre H, Callaway L. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care 2014; 37(5): 1484-93
216. Montes A, Walden CE, Knopp RH, Cheung M, Chapman MB, Albers JJ. Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Arteriosclerosis 1984; 4(4): 407-17
217. Palinski W. Maternal-fetal cholesterol transport in the placenta: good, bad, and target for modulation. Circ Res 2009; 104(5): 569-71
218. Napoli C, D'Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolaemia. Intimal accumulation of low-density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997; 100(11): 2680-90
219. Napoli C, Glass C, Witztum J, Deutsch R, D'Armiento F, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early 82 atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 1999; 354(9186): 1234-41
220. Liguori A, D'Armiento FP, Palagiano A, et al. Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids. Brit J Obstet Gynecol 2007; 114(12): 1547-56
221. Ethier-Chiasson M, Duchesne A, Forest JC, et al. Influence of maternal lipid profile on placental protein expression of LDLr and SR-BI. Biochem Biophys Res Commun 2007; 359(1): 8-14
222. Palinski W. Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease. Circulation 2014; 129(20): 2066-77
223. Ryoo S, Lemmon C, Soucy K, et al. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res 2006; 99(9): 951-60
224. Ryoo S, Gupta G, Benjo A, et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 2008; 102(8): 923-32
225. Stroes E, Kastelein J, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolaemia. J Clin Invest 1997; 99(1): 41-6
226. Cosentino F, Hürlimann D, Gatti C, et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 2008; 94(4): 487-92
227. Leiva A, Fuenzalida B, Sobrevia B, Pardo F, Sobrevia L. Maternal supraphysiological hypercholesterolaemia leads to reduced nitric oxide synthase activity associated with reduced levels of tetrahydrobiopterin in HUVEC. Atherosclerosis 2014; 235(2): e37
228. O'Driscoll G, Green D, Taylor R. Simvastatin, an HMG–coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95(5): 1126-31
229. Laufs U, La Fata V, Plutzky J, Liao J. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97(12): 1129-35
230. Liao J, Shin W, Lee W, Clark S. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270(1): 319-24
231. Vidal F, Colome C, Martinez-Gonzalez J, Badimon L. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells. Eur J Biochem 1998; 252(3): 378-84
232. Jimenez A, Arriero M, Lopez-Blaya A, et al. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolaemic rabbits. Circulation 2001; 104(15): 1822-30
233. Fleming I, Mohamed A, Galle J, et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 2005; 65(4): 897-906
234. Aoki C, Nakano A, Tanaka S, et al. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol 2012; 156(1): 55-61
235. Fukuda S, Horiguchi M, Yamaguti K, et al. Association of monoamine-synthesizing genes with the depression tendency and personality in chronic fatigue syndrome patients. Life Sci 2013; 92(3): 183-86
236. Wyss CA, Koepfli P, Namdar M, et al. Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging 2005; 32(1): 84-91
237. Alexander L, Kutz J, Kenney W. Tetrahydrobiopterin increases NO-dependent vasodilation in hypercholesterolaemic human skin through eNOS-coupling mechanisms. Am J Physiol 2013; 304(2): R164-9
238. Ma S, Ma CC. Recent developments in the effects of nitric oxidedonating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide. Vascul Pharmacol 2014; 63(2): 63-70
239. Dulak J, Polus M, Guevara I, Polus A, Hartwich J, Dembiska-Kie&6; A. Regulation of inducible nitric oxide synthase (iNOS) and GTP cyclohydrolase I (GTP-CH I) gene expression by ox-LDL in rat vascular smooth muscle cells. J Physiol Pharmacol 1997; 48(4): 689-97
240. Dulak J, Polus M, Guevara I, et al. Oxidized low-density lipoprotein inhibits inducible nitric oxide synthase, GTP cyclohydrolase I, and transforming growth factor beta gene expression in rat macrophages. J Physiol Pharmacol 1999; 50(3): 429-41
241. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996; 271(37): 22810-4
242. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin: counterbalancing allosteric modulators of nitric oxide synthase. J Biol Chem 1997; 272(41): 25907-12
243. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997; 272(30): 18522-5
244. García-Cardeña G, Martasek P, Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 1997; 272(41): 25437-440
245. Michel T, Feron O. Nitric oxide synthases: which, where, how and why? J Clin Invest 1997; 100(9): 2146-52
246. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL. Hypercholesterolaemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 1999; 103(6): 897-905
247. Feron O, Dessy C, Desager JP, Balligand JL. Hydroxymethylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 2001; 103(1): 113-8
248. Laursen JB, Somers M, Kurz S, et al. Endothelial regulation of vasomotion in ApoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001; 103(9): 1282-8
249. Pritchard Jr KA, Groszek L, Smalley DM, et al. Native low density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995; 77(3): 510-8
250. Heinloth A, Heermeier K, Raff U, Wanner C, Galle J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J Am Soc Nephrol 2000; 11(10): 1819-25
251. Stepp DW, Ou J, Ackerman AW, Welak S, Klick D, Pritchard KA. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol 2002; 283(2): H750-9
252. Mason RP, Kubant R, Heeba G, et al. Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction. Pharm Res 2008; 25(8): 1798-806
253. Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in apoE-knockout mice. Arterioscler Thromb Vasc Biol 2004; 24(3): 445-50
254. Wohlfart P, Xu H, Endlich A, et al. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther 2008; 325(2): 370-9
255. Xia N, Daiber A, Habermeier A, et al. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein e knockout mice. J Pharmacol Exp Ther 2010; 335(1): 149-54
256. Förstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol 2011; 164(2): 213-23
257. Nickenig G, Baumer AT, Temur Y, Kebben D, Jockenhovel F, Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolaemic men. Circulation 1999; 100(21): 2131-4
258. Moncada S, Palmer RMJ, Higgs EA. The biological significance of nitric oxide formation from L-arginine. Biochem Soc Trans 1989; 17(4): 642-4
259. Moncada S. The 1991 Ulf von Euler lecture: the L-arginine: nitric oxide pathway. Acta Physiol Scand 1992; 145(3): 201-7
260. Green LC, Wagner JG, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and (lSN)-nitrate in biological fluid. Anal Biochem 1982; 126(1): 131
261. Schindler AE, Anderer M, Liebich HM. Cholesterol in amniotic fluid, maternal and umbilical cord blood. Arch Gynecol 1978; 226(4): 289-96
262. Marseille-Tremblay C, Ethier-Chiasson M, Forest J, et al. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev 2008; 75(6): 1054-62
263. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011; 28(9): 53-9
264. Augsten M, Hackl H, Ebner B, et al. Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells. Physiol Genomics 2011; 43(22): 1255-62
265. Sreckovic I, Birner-Gruenberger R, Besenboeck C, et al. Gestational diabetes mellitus modulates neonatal high-density lipoprotein compositions and its functional heterogeneity. Biochim Biophys Acta 2014; 1841(11): 1619-27
266. Eslamian L, Akbari S, Marsoosi V, Jamal A. Association between fetal overgrowth and metabolic parameters in cord blood of newborns of women with GDM. Minerva Med 2013; 104(3): 317-24
267. Khoury J, Amundsen AL, Tonstad S, et al. Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolaemia. Acta Obstet Gynecol Scand 2009; 88(2): 222-6
268. Rasool HA, Abdul Rahman AS, Abd Ghaffar NA, Nik Mahmood NM, Wong AR. Abnormal microvascular reactivity with hypercholesterolaemia in pregnancy. Malays J Med Sci 2010; 17(4): 14-9
269. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolaemia and atherosclerosis. Circ Res 1989; 64(5): 900-14
270. Herrera E, Desoye G. Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm Mol Biol Clin Investig 2015; Aug 18: doi: 10.1515/hmbci.2015.0025
271. Son GH, Kwon JY, Kim YH, et al. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010; 89(5): 700-4
272. Olmos PR, Rigotti A, Busso D, et al. Maternal hypertriglyceridemia: A link between maternal overweight-obesity and macrosomia in gestational diabetes. Obesity (Silver Spring) 2014; 22(10): 2156-63
273. Barradas MA, Mikhailidis DP, Dandona P. The effect of nonesterified fatty acids on vascular ADP-degrading enzyme activity. Diabetes Res Clin Pract 1987; 3(1): 9-19
274. Barradas MAI, Mikhailidis DP, Dandona P. ADPase activity in human maternal and cord blood: possible evidence for a placentaspecific vascular protective mechanism. Int J Gynaecol Obstet 1990; 31(1): 15-20
275. Marcus AJ, Broekman MJ, Drosopoulos JH, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99(6): 1351-60
276. Marcus AJ, Broekman MJ, Drosopoulos JH, et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 2005; 31(2): 234-46
277. Takaishi K, Miyoshi J, Matsumura T, et al. Hypertriglyceridemic acute pancreatitis during pregnancy: prevention with diet therapy and omega-3 fatty acids in the following pregnancy. Nutrition 2009; 25(11-12): 1094-7
278. Russi G. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis. Transfus Apher Sci 2015; 53(3): 283-7
279. Eddy JJ, Gideonsen MD, Song JY, et al. Pancreatitis in pregnancy. Obstet Gynecol 2008; 112(5): 1075-81
280. Cheang CU, Ho SW, Tee YT, Su CF, Chen GD. Acute necrotizing pancreatitis complicating uteroplacental apoplexy. Taiwan J Obstet Gynecol 2007; 46(1): 64-7
281. Bednov A, Espinoza J, Betancourt A, Vedernikov Y, Belfort M, Yallampalli C. L-Arginine prevents hypoxia-induced vasoconstriction in dual-perfused human placental cotyledons. Placenta 2015; 36(11): 1254-9
282. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353(9160): 1258-65
283. Ornaghi S, Mueller M, Barnea ER, et al. Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis. Birth Defects Res C Embryo Today 2015; 105(3): 209-25
284. Sikkema JM, Franx A, Bruinse HW, et al. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 2002; 23(4): 337-42
285. Stevens DU, Al-Nasiry S, Bulten J, et al. Decidual vasculopathy in preeclampsia: lesion characteristics relate to disease severity and perinatal outcome. Placenta 2013; 34(9): 805-9
286. Baltajian KI, Hecht JL, Wenger JB, et al. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy 2014; 33(4): 427-39
287. Saldeen P, Olofsson P, Laurini RN. Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism. J Matern Fetal Neonatal Med 2002; 12(3): 165-71
288. Daskalakis GI, Marinopoulos S, Krielesi V, et al. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol Scand. 2008; 87(4): 403-7
289. Henriksen T, Clausen T. The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in wellnourished populations. Acta Obstet Gynecol Scand 2002; 81(2): 112-4
290. Mutlu-Türkoglu U, Aykaç-Toker G, Ibrahimoglu L, Ademoglu E, Uysal M. Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest 1999; 48(4): 247-50
291. Pathak N, Sawhney H, Vasishta K, Majumdar S. Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia. Aust N Z J Obstet Gynaecol 1999; 39(4): 484-7
292. Shaamash AH, Elsnosy ED, Makhlouf AM, Zakhari MM, Ibrahim OA, EL-dien HM. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2000; 68(3): 207-14
293. Yanik FF, Amanvermez R, Koçak I, Yanik A, Celik C. Serum nitric oxide and glutathione levels in preeclamptic and normotensive women during labor. Gynecol Obstet Invest 2001; 51(2): 110-5
294. Xiang W, Chen H, Xu X, Zhang M, Jiang R. Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia. Int J Gynaecol Obstet 2005; 89(2): 103-7
295. Mao D, Che J, Li K, et al. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet 2010; 282(4): 371-5
296. Chedraui P, Solis EJ, Bocci G, et al. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med 2013; 26(3): 226-32
297. Demircan Sezer S, Küçük M, Nergiz Avcıoğlu S, et al. Comparison of maternal and umbilical cord blood HIF-1α and nitric oxide levels in early and late onset preeclamptic pregnancies. Gynecol Endocrinol 2015; 25: 1-4
298. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171(4): 944-8
299. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995; 173(3): 714-8
300. Davidge ST, Signorella AP, Hubel CA, Lykins DL, Roberts JM. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 1996; 28(5): 758-64
301. Silver RK, Kupferminc MJ, Russell TL, Adler L, Mullen TA, Caplan MS. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 1996; 175(4): 1013-7
302. Nobunaga T, Tokugawa Y, Hashimoto K, et al. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 1996; 41(3): 189-93
303. Begum S, Yamasaki M, Mochizuki M. Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 1996; 22(6): 551-9
304. Conrad KP, Kerchner LJ, Mosher MD. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol 1999; 277(1): F48-57
305. Egerman RS, Andersen RN, Manejwala FM, Sibai BM. Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women. Am J Obstet Gynecol 1999; 181(4): 921-3
306. Ranta V, Viinikka L, Halmesmäki E, Ylikorkala O. Nitric oxide production with preeclampsia. Obstet Gynecol 1999; 93(3): 442-5
307. Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J. Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol 1999; 93(6): 958-63
308. Nishikawa S, Miyamoto A, Yamamoto H, Ohshika H, Kudo R. The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci 2000; 67(12): 1447-54
309. Yoneyama Y, Suzuki S, Sawa R, et al. Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia. Am J Obstet Gynecol 2002; 187(3): 676-80
310. Vural P. Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta 2002; 317(1-2): 65-70
311. Choi JW, Im MW, Pai SH. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002; 32(3): 257-63
312. Celik O, Hascalik S, Turkoz Y, Hascalik M, Gokdeniz R. Cerebrospinal fluid nitric oxide level changes in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 111(2): 141-5
313. Var A, Yildirim Y, Onur E, et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 2003; 56(4): 221-4
314. Paşaoğlu H, Bulduk G, Oğüş E, Paşaoğlu A, Onalan G. Nitric oxide, lipid peroxides, and uric acid levels in pre-eclampsia and eclampsia. Tohoku J Exp Med 2004; 202(2): 87-92
315. Aydin S, Benian A, Madazli R, Uludag S, Uzun H, Kaya S. Plasma malondialdehyde, superoxide dismutase, E-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004; 113(1): 21-5
316. D'Anna R, Baviera G, Corrado F, Ientile R, Granese D, Stella NC. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand 2004; 83(2): 155-8
317. Schiessl B, Strasburger C, Bidlingmaier M, et al. Plasma and urine concentrations of nitrite/nitrate and cyclic guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet 2006; 274(3): 150-4
318. McCord N, Ayuk P, McMahon M, Boyd RC, Sargent I, Redman C. System y+ arginine transport and NO production in peripheral blood mononuclear cells in pregnancy and preeclampsia. Hypertension 2006; 47(1): 109-15
319. Teran E, Escudero C, Moya W. Abnormal release of nitric oxide from nitrosoprotein in preeclampsia. Int J Gynaecol Obstet 2006; 92(3): 260-1
320. Sandrim VC, Palei AC, Metzger IF, Cavalli RC, Duarte G, Tanus-Santos JE. Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia. Clin Chim Acta 2010; 411(19-20): 1457-60
321. Ehsanipoor RM, Fortson W, Fitzmaurice LE, et al. Nitric oxide and carbon monoxide production and metabolism in preeclampsia. Reprod Sci 2013; 20(5): 542-8
322. Pimentel AM, Pereira NR, Costa CA, et al. L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia. Hypertens Res 2013; 36(9): 783-8
323. Sakar MN, Atay AE, Demir S, et al. Association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide levels in patients with preeclampsia and gestational hypertension. J Matern Fetal Neonatal Med 2015; 14: 1-6
324. Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 2004; 190(3): 817-24
325. Li X, Li C, Dong X, Gou W. MicroRNA-155 inhibits migration of trophoblast cells and contributes to the pathogenesis of severe preeclampsia by regulating endothelial nitric oxide synthase. Mol Med Rep 2014; 10(1): 550-4
326. Laskowska M, Laskowska K, Oleszczuk J. The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction. J Matern Fetal Neonatal Med 2015; 28(1): 26-32
327. Di Iulio JL, Gude NM, King RG, Li CG, Rand MJ, Brennecke SP. Human placental nitric oxide synthase activity is not altered in diabetes. Clin Sci 1999; 97(1): 123-8
328. Farías M, San Martín R, Puebla C, et al. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol 2006; 208(2): 451-60
329. Malti N, Merzouk H, Merzouk SA, et al. Oxidative stress and maternal obesity: feto-placental unit interaction. Placenta 2014; 35(6): 411-6
330. Capobianco E, Martínez N, Fornes D, et al. PPAR activation as a regulator of lipid metabolic, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patiens. Mol Cell Endocrinol 2013; 377(1-2): 7-15
331. Akiibinu MO, Kolawole TO, Ekun OA, Akiibinu SO. Metabolic dysfunctions in Nigerian pre-eclamptics. Arch Gynecol Obstet 2013; 288(5): 1021-6.